What is NDC 72865-238?

72865-238 is the product NDC for Levothyroxine Sodium, Levothyroxine sodium .075 mg/1 tablet, listed with the FDA by XLCare Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

XLCare Pharmaceuticals, Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Levothyroxine Sodium?

528 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Levothyroxine Sodium NDC 72865-238 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72865-238Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72865-0238Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72865-238-10	72865023810	1000 TABLET in 1 BOTTLE (72865-238-10)Marketed from Jan 18, 2023
72865-238-90	72865023890	90 TABLET in 1 BOTTLE (72865-238-90)Marketed from Jan 18, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levothyroxine Sodium
Generic name (nonproprietary): levothyroxine sodium
Active ingredients: Levothyroxine sodium — .075 mg/1
Dosage form: Tablet
Route: Oral
Labeler: XLCare Pharmaceuticals, Inc.NDC labeler code 72865
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215259
Marketing start: Jan 18, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Thyroxine (Chemical structure)
Identifiers: Product ID 72865-238_16376b6d-2936-4208-ab94-3e0969dce769SPL ID 16376b6d-2936-4208-ab94-3e0969dce769SPL set ID 51a27110-e787-409b-98ba-c6471d0ad5cfRxCUI 892246, 892251, 892255, 966220, 966221, 966222, 966224, 966225, 966248, 966249, 966253, 966270UNII 9J765S329GUPC 0372865240106, 0372865242100, 0372865243107, 0372865241103, 0372865246108, 0372865245101, 0372865244104, 0372865237106, 0372865237908, 0372865247105, 0372865236109, 0372865239100, 0372865238905, 0372865238103
Pharmacologic class: l-Thyroxine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472865023810 followed by a unit qualifier and the quantity

Package 72865-0238-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 6, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Hypothyroidism Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use: Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72865-238

What is NDC 72865-238?: 72865-238 is the product NDC for Levothyroxine Sodium, Levothyroxine sodium .075 mg/1 tablet, listed with the FDA by XLCare Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Levothyroxine Sodium.
What is the active ingredient?: Levothyroxine sodium.
Who is the labeler?: XLCare Pharmaceuticals, Inc., NDC labeler code 72865. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Levothyroxine Sodium?: 528 other product NDCs are listed under this name. See all Levothyroxine Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Levothyroxine Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Levothyroxine Sodium	Levothyroxine sodium .05 mg/1	TabletOral	Coupler LLC	67046-0819	67046-0819-03
Levothyroxine Sodium	Levothyroxine sodium .137 mg/1	TabletOral	Coupler LLC	67046-0972	67046-0972-03
Levothyroxine Sodium	Levothyroxine sodium .2 mg/1	TabletOral	Coupler LLC	67046-0387	67046-0387-03
Levothyroxine Sodium	Levothyroxine sodium .125 mg/1	TabletOral	Coupler LLC	67046-0951	67046-0951-03
Levothyroxine Sodium	Levothyroxine sodium 100 ug/1	TabletOral	Coupler LLC	67046-1679	67046-1679-03
Levothyroxine Sodium	Levothyroxine sodium .175 mg/1	TabletOral	Coupler LLC	67046-0517	67046-0517-03
Levothyroxine Sodium	Levothyroxine sodium .1 mg/1	TabletOral	Coupler LLC	67046-0569	67046-0569-03
Levothyroxine Sodium	Levothyroxine sodium .15 mg/1	TabletOral	Coupler LLC	67046-0515	67046-0515-03
Levothyroxine Sodium	Levothyroxine sodium .075 mg/1	TabletOral	Coupler LLC	67046-0801	67046-0801-03
Levothyroxine Sodium	Levothyroxine sodium .025 mg/1	TabletOral	Coupler LLC	67046-0828	67046-0828-03

All 529 Levothyroxine Sodium NDCs

Other NDCs under ANDA 215259

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215259
Product	Strength	Form · route	Labeler	Product NDC
Levothyroxine Sodium	Levothyroxine sodium .075 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-286
Levothyroxine Sodium	Levothyroxine sodium .025 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-284
Levothyroxine Sodium	Levothyroxine sodium .05 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-285
Levothyroxine Sodium	Levothyroxine sodium .125 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-290
Levothyroxine Sodium	Levothyroxine sodium .088 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-287
Levothyroxine Sodium	Levothyroxine sodium .1 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-288
Levothyroxine Sodium	Levothyroxine sodium .112 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-289
Levothyroxine Sodium	Levothyroxine sodium .2 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-294
Levothyroxine Sodium	Levothyroxine sodium .137 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-291
Levothyroxine Sodium	Levothyroxine sodium .15 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-292
Levothyroxine Sodium	Levothyroxine sodium .175 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-293
Levothyroxine Sodium	Levothyroxine sodium .3 mg/1	TabletOral	Camber Pharmaceuticals, Inc.	31722-295
Levothyroxine Sodium	Levothyroxine sodium .025 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-236
Levothyroxine Sodium	Levothyroxine sodium .1 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-240
Levothyroxine Sodium	Levothyroxine sodium .05 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-237
Levothyroxine Sodium	Levothyroxine sodium .088 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-239
Levothyroxine Sodium	Levothyroxine sodium .137 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-243
Levothyroxine Sodium	Levothyroxine sodium .112 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-241
Levothyroxine Sodium	Levothyroxine sodium .125 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-242
Levothyroxine Sodium	Levothyroxine sodium .3 mg/1	TabletOral	XLCare Pharmaceuticals, Inc.	72865-247

Showing 20 of 23.